SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-049201
Filing Date
2024-04-26
Accepted
2024-04-26 16:27:34
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS xene-2024-ars-annualrepo.pdf ARS 840836
  Complete submission text file 0000950170-24-049201.txt   1158931
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36687 | Film No.: 24884262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)